GHB Analog-Containing Product Demand High, NEJM Researchers Report
This article was originally published in The Tan Sheet
Executive Summary
Extensive industrial use of the GHB analog 1,4-butanediol (BD), in conjunction with the flexibility and anonymity of Internet marketing, "ensures a continued supply that is almost impossible to regulate," researchers say in the Jan. 11 New England Journal of Medicine.